BIO-Europe Spring 2009
Date : March 16-18, 2009
Venue : Milano Convention Centre (MIC),
Milan,
Italy
Conference
As the springtime counterpart to BIO-Europe, BIO-Europe Spring® continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s acclaimed partnering system, partneringONE™, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the biotech value chain.
In addition to productive partnering, BIO-Europe Spring offers high level workshops, panels, company presentations, and a lively exhibition. The program offers executive level panelists who openly share their insight and opinion on many important industry issues. The company presentation tracks provide a forum for innovative start-ups, established biotech companies, and large and midsize pharma to present information on products, partnering opportunities and corporate strategy.
Advisory Board
The following industry experts have accepted to be on the BIO-Europe Spring Advisory board.
* Pam Demain, Executive Director, Corporate Licensing, Merck & Co., Inc.
* Dr. Juergen Heitmann, Head of Out-Licensing, Novartis Pharma
* Wendy Johnson, Venture partner/CEO Aires Pharmaceuticals, ProQuest Investments & Aries Pharmaceuticals
* Dr. Olivier Litzka, Partner, Edmond de Rothschild Investment Partners
* Joel Jean-Mairet, Managing Partner, ysios capital partners
* Martina Molsbergen, VP Business Development Licensing, Crucell BV
* Ian Nicholson, CEO, Chroma Therapeutics Ltd
* Dr. Pedro de Noronha Pissarra, CEO, Biotecnol SA
* Dr. Ellen Strahlman, VP, Licensing, Worldwide Business Development, Pfizer, Inc.
* Dr. Robert Wills, VP, Alliance Management, Pharmaceuticals Group, Johnson & Johnson
* Christopher Yochim, Associate Director External Relations, AstraZeneca
Contact
Constantine Theodoropulos
EBD Group
T: +1 617 292 7319
M: +1 617 816 4637
ctheodoropulos@ebdgroup.com more
